Assessment of the efficacy and safety of lenvatinib for the treatment of radioiodine-refractory differentiated thyroid cancer in real-life practice in Russia

被引：0
|
作者：
Borodavina, E. [1 ]
Isaev, P. [1 ]
Shurinov, A. [1 ]
Krylov, V. [1 ]
机构：
[1] A Tsyb Med Radiol Res Ctr, Radionuclide Therapy Dept, Obninsk, Russia
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
关键词：
D O I：
10.1016/j.annonc.2020.08.1411
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1923P
引用
收藏
页码：S1089 / S1090
页数：2
相关论文
共 50 条
  • [1] Lenvatinib for the Treatment of Radioiodine-Refractory Thyroid Cancer in Real-Life Practice
    Berdelou, Amandine
    Borget, Isabelle
    Godbert, Yann
    Nguyen, Thierry
    Garcia, Marie-Eve
    Chougnet, Cecile N.
    Ferru, Aurelie
    Buffet, Camille
    Chabre, Olivier
    Huillard, Olivier
    Leboulleux, Sophie
    Schlumberger, Martin
    [J]. THYROID, 2018, 28 (01) : 72 - 78
  • [2] Lenvatinib in Advanced Radioiodine-refractory Thyroid Cancer: A Snapshot of Real-life Clinical Practice
    Nervo, Alice
    Gallo, Marco
    Sama, Maria Teresa
    Felicetti, Francesco
    Alfano, Martina
    Migliore, Enrica
    Marchisio, Filippo
    Berardelli, Rita
    Arvat, Emanuela
    Piovesan, Alessandro
    [J]. ANTICANCER RESEARCH, 2018, 38 (03) : 1643 - 1649
  • [3] Defining Radioiodine-Refractory Differentiated Thyroid Cancer: Efficacy and Safety of Lenvatinib by Radioiodine-Refractory Criteria in the SELECT Trial
    Kiyota, Naomi
    Robinson, Bruce
    Shah, Manisha
    Hoff, Ana O.
    Taylor, Matthew H.
    Li, Di
    Dutcus, Corina E.
    Lee, Eun Kyung
    Kim, Sung-Bae
    Tahara, Makoto
    [J]. THYROID, 2017, 27 (09) : 1135 - 1141
  • [4] Evaluation of the QTc interval during lenvatinib treatment in radioiodine-refractory differentiated thyroid cancer: reports from the real-life clinical practice
    Marina, Michela
    Serra, Maria Francesca
    Del Rio, Paolo
    Ceresini, Graziano
    [J]. FUTURE ONCOLOGY, 2019, 15 (24S) : 7 - 12
  • [5] Survival Predictors of Radioiodine-refractory Differentiated Thyroid Cancer Treated With Lenvatinib in Real Life
    Marotta, Vincenzo
    Rocco, Domenico
    Crocco, Anna
    Deiana, Maria Grazia
    Martinelli, Ruggero
    Di Gennaro, Francesca
    Valeriani, Mariafelicia
    Valvano, Luca
    Caleo, Alessia
    Pezzullo, Luciano
    Faggiano, Antongiulio
    Vitale, Mario
    Monti, Salvatore
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2024, 109 (10): : 2541 - 2552
  • [6] Use of lenvatinib in the treatment of radioiodine-refractory differentiated thyroid cancer: a multidisciplinary perspective for daily practice
    Capdevila, Jaume
    Deandreis, Desiree'
    Durante, Cosimo
    Leboulleux, Sophie
    Luster, Markus
    Netea-Maier, Romana
    Newbold, Kate
    Singer, Susanne
    Sykiotis, Gerasimos P.
    Bartes, Beate
    Farnell, Kate
    Locati, Laura Deborah
    [J]. EUROPEAN THYROID JOURNAL, 2023, 12 (05)
  • [7] Tumor growth rate and lenvatinib efficacy in radioiodine-refractory differentiated thyroid cancer
    Leboulleux, S.
    Lee, E. K.
    Bastholt, L.
    Tahara, M.
    Wirth, L. J.
    Sherman, S. I.
    Robinson, B. G.
    Teng, A.
    Joshi, P.
    Misir, S.
    Dutcus, C. E.
    Tuttle, R. M.
    Schlumberger, M. J.
    [J]. ANNALS OF ONCOLOGY, 2018, 29
  • [8] Lenvatinib - A multikinase inhibitor for radioiodine-refractory differentiated thyroid cancer
    Hewett, Yvonne
    Ghimire, Subash
    Farooqi, Bilal
    Shah, Binay K.
    [J]. JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2018, 24 (01) : 28 - 32
  • [9] Exposure–response analysis and simulation of lenvatinib safety and efficacy in patients with radioiodine-refractory differentiated thyroid cancer
    Seiichi Hayato
    Robert Shumaker
    Jim Ferry
    Terri Binder
    Corina E. Dutcus
    Ziad Hussein
    [J]. Cancer Chemotherapy and Pharmacology, 2018, 82 : 971 - 978
  • [10] Efficacy and Limitations of Lenvatinib Therapy for Radioiodine-Refractory Differentiated Thyroid Cancer: Real-World Experiences
    Masaki, Chie
    Sugino, Kiminori
    Saito, Naoko
    Akaishi, Junko
    Hames, Kiyomi Y.
    Tomoda, Chisato
    Suzuki, Akifumi
    Matsuzu, Kenichi
    Uruno, Takashi
    Ohkuwa, Keiko
    Kitagawa, Wataru
    Nagahama, Mitsuji
    Ito, Koichi
    [J]. THYROID, 2020, 30 (02) : 214 - 221
12345